Health
Study explores women’s interest in long-acting injectable antiretroviral therapy – News-Medical.Net
A study led by Columbia University Mailman School of Public Health researchers examines attitudes toward long-acting injectable (LAI) HIV therapies, among women…
A study led by Columbia University Mailman School of Public Health researchers examines attitudes toward long-acting injectable (LAI) HIV therapies, among women with a history of injection–including medical purposes and substance use. The findings appear in the journal AIDS Patient Care and STDs.
Currently, most HIV therapies for treatment and prevention (pre-exposure prophylaxis, PrEP) necessitate daily pills, which pose barriers to adherence. Recently, however, LAI for HIV has emerged as an alternative…
-
Noosa News18 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General18 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
Noosa News10 hours agoNew playground equipment encourages children to learn through ‘risky play’
-
General7 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania